Among all the chronic autoimmune rheumatic disorders, Sjogren's disease (SD) is among
the most difficult to evaluate and manage. Clinicians are frequently challenged to …

Objective The Sjögren's Syndrome Foundation clinical practice guidelines (CPGs) are
designed to improve quality and consistency of care in Sjögren's syndrome by offering …

The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in
recent decades: treatment decisions remain challenging in clinical practice, without a …

Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that is characterized by
a triad of symptoms that affect all patients (dryness, pain and fatigue). In addition, systemic …

The treatment of primary Sjögren's syndrome (SS) is based principally on the management
of sicca features and systemic manifestations. Sicca manifestations are treated …

Objectives: The objective of this study is to develop clinical practice guideline (CPG) for
Sjögren's syndrome (SS) based on recently available clinical and therapeutic evidences …

Primary Sjögren syndrome (pSS) is a progressive autoimmune disease characterized by
sicca and systemic manifestations. In this Review, we summarize the available data on …

For many years primary Sjögren's syndrome (pSS) has been considered an orphan disease,
since no specific therapies were recognized as being capable of contrasting the …

Lymphocytic infiltration of different exocrine and non-exocrine epithelia is the pathological
hallmark of primary Sjögren's syndrome, whereas involvement of salivary and lachrymal …

To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome
(pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of …